Vitality Biopharma, Inc. (VBIO) SEC Filing 8-K Material Event for the period ending Monday, October 22, 2018

Vitality Biopharma, Inc.

CIK: 1438943 Ticker: VBIO

View differences made from one to another to evaluate Vitality Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Vitality Biopharma, Inc..


Assess how Vitality Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Vitality Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Vitality Biopharma, Inc. provided additional information to their SEC Filing as exhibits

Ticker: VBIO
CIK: 1438943
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-014894
Submitted to the SEC: Fri Oct 26 2018 4:42:38 PM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Monday, October 22, 2018
Industry: Commercial Physical And Biological Research
  1. Financial Exhibit
  2. New Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: